Clinical Trials Browser

Phase 1 × Recruiting × Neuroblastoma × Clear all

NCT06104488 2026-02-25

A Study of Avutometinib for People With Solid Tumor Cancers

Phase 1 Recruiting

Brain Neoplasms, Neoplasms, Neuroblastoma, Central Nervous System Neoplasms, Neurofibroma, Plexiform

NCT06995872 2026-02-17

Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory Neuroblastoma

Phase 1 Recruiting

Neuroblastoma

NCT07172958 2026-01-27

SABRE

Phase 1 Recruiting

CNSGenitourinarySarcoma

Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing

NCT05650749 2025-12-29

GPC2

Phase 1 Recruiting

CNSOther solid neoplasm

Neuroblastoma, Retinoblastoma

NCT05400603 2025-12-26

Aflac-NBL-2002

Phase 1 Recruiting

Neuroblastoma, Osteosarcoma

NCT07007117 2025-12-26

PHOX2B

Phase 1 Recruiting

Neuroblastoma

NCT03966651 2025-11-18

NEUROBLU 02

Phase 1 Recruiting

Neuroblastoma

NCT04084067 2025-11-04

Indocyanine Green (ICG) Guided Tumor Resection

Phase 1 Recruiting

CNSGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Lymphoma, Neoplasms, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

NCT04897321 2025-10-24

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

Phase 1 Recruiting

CNSDermatologicGastrointestinalGenitourinarySarcoma

Adrenal Cortex Neoplasms, Carcinoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma, Hepatoblastoma, Sarcoma, Clear Cell, Neurofibrosarcoma, Rhabdoid Tumor, Desmoplastic Small Round Cell Tumor

NCT02508038 2025-10-16

Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

Phase 1 Recruiting

CNSLymphoidMyeloidOther hematologic neoplasmSarcoma

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Osteosarcoma, Leukemia, Myeloid, Acute, Neuroectodermal Tumors, Primitive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT04337177 2025-09-23

Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors

Phase 1 Recruiting

CNSGastrointestinalSarcoma

Medulloblastoma, Neuroblastoma, Recurrence, Rhabdomyosarcoma, Sarcoma, Ewing, Hepatoblastoma

NCT03294954 2025-09-19

GINAKIT2

Phase 1 Recruiting

Neuroblastoma

NCT03721068 2025-09-09

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

Phase 1 Recruiting

Gaucher Disease, Neuroblastoma, Osteosarcoma

NCT07027748 2025-07-14

Feasibility Study of Prolonged Administration of Naxitamab, Irinotecan, and Temozolomide for Patients With Relapsed or Refractory Neuroblastoma

Phase 1 Recruiting

Neuroblastoma

NCT06041516 2025-07-11

Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors and Carcinomas

Phase 1 Recruiting

CNSEndocrineNET

Neuroblastoma, Paraganglioma, Pheochromocytoma, Adrenocortical Carcinoma, Carcinoma, Neuroendocrine, Neuroendocrine Tumors

NCT06485947 2025-07-08

DBPilot

Phase 1 Recruiting

Neuroblastoma

NCT06674265 2025-04-09

Safety and Efficacy of Systemic Allogenic NK Cells in R/R Neuroblastoma

Phase 1 Recruiting

Neuroblastoma, Recurrence

NCT05701306 2025-02-25

APG-115 Alone or in Combination With APG-2575 in Children With Recurrent or Refractory Neuroblastoma or Solid Tumors

Phase 1 Recruiting

Neuroblastoma

NCT06631391 2025-02-20

Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.

Phase 1 Recruiting

Neuroblastoma

NCT06751134 2025-02-07

Chimeric Natural Killer Receptor-Universal T Cells for Relapsed or Refractory Neuroblastoma

Phase 1 Recruiting

Neuroblastoma, Recurrence

NCT05990751 2024-05-31

MAGNETO

Phase 1 Recruiting

Neuroblastoma